Scott F. Drees

Biography

Prior to joining Nuvectra as President and CEO, Mr. Drees was a founding partner of the Algostim and Pelvistim companies and served as a full-time consultant to the QiG group, since 2009. In addition, from January 2008 to July 2015, Mr. Drees also served as the President and CEO of Neuromodulation Ventures, LLC, a private company focused on incubating new neurostimulation companies. Mr. Drees has 35 years of experience in the medical device industry and has spent his last 20 years focused on Neuromodulation markets and therapies. He has served in executive positions from 1996-2006, as founding Division President and, later Executive VP, Worldwide Sales & Marketing at Advanced Neuromodulation Systems, Inc (ANSI), a company acquired by St. Jude Medical, Inc. in 2005. Between 1981 and 1996, Mr. Drees has also held a variety of positions at St. Jude Medical, Boston Scientific and Johnson and Johnson’s Codman Division. Mr Drees currently serves as a Director of Neuros Medical, Inc. a privately held neurostimulation company and was a founding member of the National Pain Foundation. He earned his B.S. Degree from St. Joseph’s University, Philadelphia. 

Research Interest

 Business